Pediatric Vaccines Market Size, Share, Growth and Industry analysis, By Type (Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Others), By Application (Newborn, Infant, Child, Dolescent) and Regional Forecast to 2034

• 

  Request a Free sample to learn more about this report

PEDIATRIC VACCINES MARKET OVERVIEW

The global pediatric vaccines market size was valued at USD 20.59 billion in 2025 and is expected to reach USD 44.93 billion by 2034, growing at a compound annual growth rate (CAGR) of about 9.06% from 2025 to 2034.

The United States Pediatric Vaccines Market size is projected at USD 6.892 Billion in 2025, the Europe Pediatric Vaccines Market size is projected at USD 4.838 Billion in 2025, and the China Pediatric Vaccines Market size is projected at USD 6.046 Billion in 2025.

The global COVID-19 pandemic has been unprecedented and staggering, with pediatric vaccines experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels.

Pediatric vaccines are administered to children and infants. It is a process and an integral part of immunization. Further, the vaccination is made to become resistant to a variety of disease-causing agents such as viruses and bacteria.

Rising prevalence of numerous diseases such as influenza, tetanus, pertussis, and diphtheria is estimated to surge market growth. Growing number of infectious and non-infectious diseases among children is anticipated to fuel market growth. Increasing government and private sector funding for developing novel vaccines. Also, growing awareness among people about immunization is estimated to fuel market growth. Rise in research and development (R&D) activities by major market players are predicted to fuel market expansion in the forthcoming years. Increasing number of approvals for vaccines and growing number of laborites globally. These factors are predicted to witness a lucrative opportunity for the growth of the market. Entry of new vaccines and high demand for the vaccines is estimated to expand market growth. However, stringent guidelines and high cost of the vaccines are expected to restrict pediatric vaccines market expansion.

PEDIATRIC VACCINES MARKET KEY FINDINGS

COVID-19 IMPACT

Outbreak of COVID-19 Negatively Impacted Market Growth

COVID-19 pandemic had a negative impact on the market. Spreading of coronavirus and increasing number of cases encouraged manufacturing of vaccines. An outbreak of COVID-19 accelerated the awareness about vaccines. Majority of the people adapted vaccines to fight against the virus and increase immunity. Adoption of vaccines helps to decrease the number of COVID-19 cases.

On the contrary, lockdown restrictions and limited access to clinics slow down the patient flow. Also, temporarily closure of non-essential care and restricted hospital access decline product adoption.

LATEST TRENDS

Prevalence of Numerous Diseases to Fuel Market Expansion

Increasing prevalence of various diseases such as influenza, tetanus, pertussis, and diphtheria is estimated to surge market growth. Vaccination helps to fight such infections and create immunity. Our body needs a robust immune system to fight against viruses and bacteria. High demand for permanent protection is predicted to surge market growth. Growing awareness about children's and adult's healthcare is projected to drive market progress. Such diseases are spread by air, direct contact, and contaminated water or food. Growing concern about fighting against such diseases and reducing the chances of infections are estimated to fuel market growth in the upcoming years.

• According to WHO/UNICEF, 85% of children worldwide received the third dose of DTP (diphtheria–tetanus–pertussis) vaccine in 2024, yet 14.3 million infants remained completely unvaccinated.

• WHO reports that about 20.6 million children missed the first measles vaccine dose in 2024—far below the 95% necessary for herd immunity.

Request a Free sample to learn more about this report

PEDIATRIC VACCINES MARKET SEGMENTATION

By Type

Based on type, the market is divided diphtheria, influenza, hepatitis, pneumococcal diseases, meningococcal diseases, and others.

Diphtheria is expected to be the leading part of the segmentation type.

By End User

Based on the end user, the market is divided into newborn, infant, child, and dolescent.

Newborn is expected to be the leading part of end user segmentation.

DRIVING FACTORS

Initiatives by Government Globally to Surge Market Progress

Increasing initiatives by government to develop vaccines are estimated to surge market growth. Growing number of funding from government and non-government to develop novel vaccines. Increase in research and development (R&D) activities and growing lab activities is anticipated to surge market expansion. Multiple companies are testing and introducing new vaccines for children and adults. Wide commercial availability of vaccines and pediatric population is expected to expand market expansion. Even support from World Health Origination (WHO) to develop novel vaccines and increasing demand to improve global health is predicted to surge market growth. Growing adoption of advanced technology in healthcare sector and rising research by professionals to develop cost-effective vaccines which are anticipated to fuel market growth. Increasing disposable income of population and growing capacity of people to afford vaccines is estimated to expand market growth. Further, government regulations to provide vaccines and arranging camps to create awareness about vaccination process. Such factors are estimated to propel pediatric vaccines market progress in the upcoming years.

• Government Immunisation Initiatives in India : India’s Mission Indradhanush vaccinated over 25.3 million children and 6.8 million pregnant women between 2014–2017, boosting full immunisation rates by 16%.

• Public Health Programs in the U.S. : The CDC’s Vaccines for Children (VFC) program, with a US $5 billion budget, provides nearly half of U.S. childhood vaccinations, targeting underserved populations.

Focus on Improving Healthcare Sector to Magnify Pediatric Vaccines Demand

Growing focus on improving healthcare sector is predicted to surge market growth. High demand for the vaccines and support from professionals is anticipated to propel market growth. Increasing focus on improving primary healthcare infrastructure is estimated to expand market growth. Adoption of vaccines played an instrumental role in minimizing the spread of numerous diseases. A high need to improve the effectiveness of existing vaccines is anticipated to fuel market growth. Further, several integration programs for children and recent awareness about antibodies are predicted to surge market growth. Additionally, rising economic growth and collaboration of national manufacturers are anticipated to accelerate market growth in the upcoming years. Vaccines help to save millions of lives, and awareness about immunization is estimated to accelerate pediatric vaccines market growth in the forthcoming years.

Importance of Vaccines among Children to Incite Market Progress

Growing importance of vaccines among children is anticipated to surge market growth. Vaccination protects children from deadly diseases such as tetanus, diphtheria, and polio. High demand for novel vaccines to save children and increase immunity. High order to reduce spreading of dangerous conditions and need to control the spread of child to child. These factors are estimated to fuel market growth. Vaccines help to build antibodies and act as a germ-fighting machine. They are safe for children and newborns. Growing number of parents are aware of the benefits of vaccines. These factors are responsible for accelerating pediatric vaccines market growth during the forecast period.

RESTRAINING FACTORS

High Cost and Stringent Guidelines to Hamper Market Growth

Stringent guidelines and the high cost of the vaccines are expected to restrict market expansion. Further presence of biosimilar at low rates is anticipated to obstruct market growth in the coming years.

• Conflict-Caused Disruptions : In Sudan, childhood vaccination fell from 90% coverage in 2022 to just 48% in 2025, leaving 838,000 children zero-dose due to conflict.

• Rising Global Misinformation : Disinformation campaigns, especially regarding measles, have contributed to outbreaks across 60 countries, with measles cases doubling in 2024.

• Request a Free sample to learn more about this report

•  

PEDIATRIC VACCINES MARKET REGIONAL INSIGHTS

Growing Research and Development Activities to Drive Market Share in North America

North America is predicted to expand pediatric vaccines market share due to growing research and development (R&D) activities. Advancement in rotavirus vaccines in the region is anticipated to surge market growth. Increasing government and private sector funding for developing novel vaccines. Also, growing awareness among people about immunization is estimated to fuel market growth. Rise in number of approvals and presence of advance technology. Along with an increase in the number of laboratories and awareness about vaccination in the region. These factors are estimated to surge market growth in the upcoming years. 

KEY INDUSTRY PLAYERS

Leading Players Adopt New Strategies to Stay Competitive

The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

• Merck : According to CDC data, more than 231 million doses of Merck’s M‑M‑R II vaccine have been administered in the U.S. over the past 30 years global.

• Pfizer : According to UNICEF, Pfizer has committed to supplying up to 260 million doses of its Prevenar 13 pneumococcal conjugate vaccine to Gavi-supported countries through 2025.

List of Top Pediatric Vaccines Companies

• Merck
• Lupin
• Takeda Pharmaceutical
• Novartis
• S K Chemicals
• AstraZeneca
• Janssen
• Shenzhen Kangtai Biological Products
• Bavarian Nordic
• Mitsubishi Tanabe Pharma
• GlaxoSmithKline
• Baxter
• LG Life Sciences
• Pfizer
• Sanofi

REPORT COVERAGE

This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.